The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals

Journal of Clinical and Experimental Neuropsychology

Volumn 35, Issue 4, 2013, Pages 421-434

  Patel, Sapna M ^a,b   Thames, April D ^a,b   Arbid, Natalie ^b   Panos, Stella E ^a,b   Castellon, Steven ^a,b   Hinkin, Charles H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Aging; Cognition; Comorbid risk factors; HIV; Neuropsychology

Indexed keywords

EID: 84876793329     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803395.2013.783000     Document Type: Article

References (89)

1. Adeyemi, O. (2007). Cardiovascular risk and risk management in HIV-infected patients. Topics in HIV Medicine, 15, 159-162.
2. Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377-381.
3. Azar, A. R., Murrell, S. A., & Mast, B. T. (2005). Race and vascular depression risk in community-dwelling older adults. American Journal of Geriatric Psychiatry, 13, 329-332.
4. Basso, M. R., & Bornstein, R. A. (2000). Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months. Journal of Clinical and Experimental Neuropsychology, 22, 208-218.
5. Becker, J. T., Kingsley, L., Mullen, J., Cohen, B.,Martin, E., Miller, E. N., Visscher, B. R. (2009). Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology, 73, 1292-1299.
6. Becker, B. W., Thames, A. D., Woo, W., Castellon, S. A., & Hinkin, C. H. (2011). Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS and Behavior, 15, 1888-1894.
7. Benjamini, Y., & Hochberg, Y. (2000). The adaptive control of the false discovery rate in multiple comparison problems. Journal of Education and Behavioral Statistics, 25, 60-83.
8. Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58, 721-728.
9. Bots, M. L., Dijk, J. M., Oren, A., & Grobbee, D. E. (2002). Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: Current evidence. Journal of Hypertension, 20, 2317-2325.
10. Brickman, A. M., Siedlecki, K. L., Muraskin, J., Manly, J. J., Luchsinger, J. A., Yeung, L. K., Stern, Y. (2011). White matter hyperintensities and cognition: Testing the reserve hypothesis. Neurobiology of Aging, 32, 1588-1598.
11. Bush, T. L., Miller, S. R., Golden, A. L., & Hale, W. E. (1989). Self-report and medical record report agreement of selected medical conditions in the elderly. American Journal of Public Health, 79, 1554-1556.
12. Carey, C. L., Woods, S. P., Rippeth, J. D., Gonzalez, R., Heaton, R. K., & Grant, I. (2006). Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS & Behavior, 10, 185-190.
13. Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999). Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study. Lancet, 353, 2093-2099.
14. Chang, L., Wang, G. J., Volkow, N. D., Ernst, T., Telang, F., Logan, J., & Fowler, J. S. (2008). Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. NeuroImage, 42, 869-878.
15. Chiesi, A., Vella, S., Dally, L. G., Pedersen, C., Danner, S., Johnson, A. M., Antunes, F. (1996). Epidemiology of AIDS dementia complex in Europe: AIDS in Europe Study Group. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 11, 39-44.
16. Childs, E. A., Lyles, R. H., Selnes, O. A., Chen, B., Miller, E. N., Cohen, B. A., McArthur, J. C. (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology, 52, 607-613.
17. Cysique, L. A., Deutsch, R., Atkinson, J. H., Young, C., Marcotte, T. D., & Dawson, L. (2007). Incident major depression does not affect neuropsychological functioning in HIV-infected men. Journal of International Neuropsychological Society, 13, 1-11.
18. Cysique, L. A., Murray, J. M., Dunbar, M., Jeyakumar, V., & Brew, B. J. (2010). A screening algorithm for HIV-associated neurocognitive disorders. HIV Medicine, 11, 642-649.
19. Dawes, S., Suarez, P., Casey, C. Y., Cherner, M., Marcotte, T. D., Letendre, S., Heaton, R. K. (2008). Variable patterns of neuropsychological performance in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology, 30, 613-626.
20. Delis, D., Kaplan, E., Kramer, J., & Ober, B. (2000). California Verbal Learning Test-II. San Antonio, TX: The Psychological Corporation.
21. Delis, D., Kramer, J., Kaplan, E., & Ober, B. (1987). California verbal learning test. San Antonio, TX: The Psychological Corporation.
22. Durvasula, R. S., Myers, H. F., Satz, P., Miller, E. N., Morgenstern, H., Richardson, M. A., Forney, D. (2000). HIV-1, cocaine, and neuropsychological performance in African American men. Journal of the Neuropsychological Society, 6, 322-335.
23. Ellis, R. J., Badiee, J., Vaida, F., Letendre, S., Heaton, R. K., Clifford, D., Grant, I. (2011). CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS, 25, 1747-1751.
24. Ettenhofer, M. L., Hinkin, C. H., Castellon, S. A., Durvasula, R., Ullman, J., Lam, M., Foley, J. (2009). Aging, neurocognition, and medication adherence in HIV infection. American Journal of Geriatric Psychiatry, 17, 281-290.
25. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. (1996). Structured Clinical Interview for DSMIV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press.
26. Foley, J., Ettenhofer,M.,Wright,M. J., Siddiqi, I., Choi, M., & Thames, A. D. (2010). Neurocognitive functioning in HIV-1 infection: Effects of cerebrovascular risk factors and age. Clinical Neuropsychologist, 24, 265-285.
27. Foley, J. M., Ettenhofer, M. L., Kim, M. S., Behdin, N., Castellon, S. A., & Hinkin, C. H. (2012). Cognitive reserve as a protective factor in older HIVpositive patients at risk for cognitive decline. Applied Neuropsychology, 19, 16-25.
28. Goggin, K. J., Kisook, S., Heaton, R. K., Atkinson, J. H., Marshall, S., & McCutchan, J. A. (1997). Neuropsychological performance in HIV-infected men with major depression. Journal of the International Neuropsychological Society, 3, 457-464.
29. Gonzalez, A., Barinas, J., & O'Cleirigh, C. (2011). Substance use: Impact on adherence and HIV medical treatment. Current HIV/AIDS Report, 8, 223-234.
30. Grant, I., Olsen, R. A., Atkinson, J. H., Heaton, R. K., Nelson, J., & McCutchan, J. A. (1993). Depressed mood does not explain neuropsychological deficits in HIV-infected persons. Neuropsychology, 7, 53-61.
31. Greenland, P., Smith, S. C., Jr., & Grundy, S. M. (2001). Improving coronary heart disease risk assessment in asymptomatic people: Role of traditional risk factors and noninvasive cardiovascular tests. Circulation, 104, 1863-1867.
32. Greub, G., Ledergerber, B., Battegay, M., Grob, P., Perrin, L., Furrer, H., Telenti, A. (2000). Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV Cohort Study. Lancet, 356, 1800-1805.
33. Heaton, R., Grant, I., & Matthews, C. (1991). Comprehensive norms for an expanded Halstead-Reitan battery: Demographic corrections, research findings, and clinical implications. Odessa, FL: Psychological Assessment Resources.
34. Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Grant, I. (2010). HIVassociated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75, 2087-2096.
35. Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., LeBlanc, S., Grant, I. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of Neurovirology, 17, 3-16.
36. Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., Abramson, I. (1995). The HNRC 500 - Neuropsychology of HIV infection at different disease stages. Journal of the International Neuropsychological Society, 1, 231-251.
37. Hilsabeck, R. C., Castellon, S. A., & Hinkin, C. H. (2005). Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clinical Infectious Diseases, 41, S38-S44.
38. Hilsabeck, R. C., Perry, W., & Hassanein, T. I. (2002). Neuropsychological impairment in patients with chronic hepatitis C. Hepatology, 35, 440-446.
39. Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., Longshore, D. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS & Behavior, 11, 185-194.
40. Hinkin, C. H., Castellon, S. A., Levine, A. J., Barclay, T. R., & Singer, E. J. (2008). Neurocognition in individuals co-infected with HIV and hepatitis C. Journal of Addictive Diseases, 27, 11-17.
41. Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., & Stefaniak, M. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18, S19-S25.
42. Hinkin, C. H., van Gorp, W. G., Satz, P., Weisman, J. D., Thommes, J., & Buckingham, S. (1992).Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals. Journal of Clinical and Experimental Neuropsychology, 14, 289-297.
43. Holmberg, S. D., Moorman, A. C., Williamson, J. M., Tong, T. C., Ward, D. J., Wood, K. C., Janssen, R. S. (2002). Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet, 360, 1747-1748.
44. Hsue, P. Y., Lo, J. C., Franklin, A., Bolger, A. F., Martin, J. N., Deeks, S. G., & Waters, D. D. (2004). Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation, 109, 1603-1608.
45. Justice, A. C., Modur, S., Tate, J. P., Althoff, K. N., Jacobson, L. P., Gebo, K., Gange, S. (2013). Predictive accuracy of the Veterans Aging Cohort Study (VACS) index for mortality with HIV infection: A North American cross cohort analysis. Journal of Acquired Immune Deficiency Syndromes, 62, 149-163.
46. Kongs, S. K., Thompson, L. L., Iverson, G. L., & Heaton, R. K. (2000). Wisconsin Card Sorting Test-64 Card, Computerized Version. Odessa, FL: Psychological Assessment Resources.
47. Laskus, T., Radkowski, M., Jablonska, J., Kibler, K., Wilkinson, J., Adair, D., & Rakela, J. (2004). Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood, 103, 3854-3859.
48. Lebech, A. M., Wiinberg, N., Kristoffersen, U. S., Hesse, B., Petersen, C. L., Gerstoft, J., & Kjaer, A. (2007). Carotid intima-media thickness in HIV patients treated with antiretroviral therapy. Clinical Physiology and Functional Imaging, 27, 173-179.
49. Letendre, S., Paulino, A. D., Rockenstein, E., Adame, A., Crews, L., Cherner, M., Masliah, E. (2007). Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. Journal of Infectious Diseases, 196, 361-370.
50. Letendre, S. L., Cherner, M., Ellis, R. J., Marquie-Beck, J., Gragg, B., Marcotte, T., Grant, I. (2005). The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: Biological correlates of disease. AIDS, 19, S72-S78.
51. Lu, Y., Robinson, M., & Zhang, F. J. (2009). Human immunodeficiency virus and hepatitis C virus coinfection: Epidemiology, natural history and the situation in China. Chinese Medical Journal, 122, 93-97.
52. Magalhaes, M. G., Greenberg, B., Hansen, H., & Glick, M. (2007). Comorbidities in older patients with HIV: A retrospective study. Journal of the American Dental Association, 138, 1468-1475.
53. Mangili, A., Gerrior, J., Tang, A. M., O'Leary, D. H., Polak, J. K., Schaefer, E. J., Wanke, C. A. (2006). Risk of cardiovascular disease in a cohort of HIVinfected adults: A study using carotid intima-media thickness and coronary artery calcium score. Clinical Infectious Diseases, 43, 1482-1489.
54. Mapou, R. L., Law, W. A., Martin, A., Kampen, D., Salazar, A. M., & Rundell, J. R. (1993). Neuropsychological performance, mood, and complaints of cognitive and motor difficulties in individuals infected with the human immunodeficiency virus. Journal of Neuropsychiatry and Clinical Neurosciences, 5, 86-93.
55. Martin, E. M., Novak, R. M., Fendrich, M., Vassileva, J., Gonzalez, R., Grbesic, S., Sworowski, L. (2004). Stroop performance in drug users classified by HIV and hepatitis C virus serostatus. Journal of the International Neuropsychological Society, 10, 298-300.
56. Mason, K. I., Campbell, A., Hawkins, P., Madhere, S., Johnson, K., & Takushi-Chinen, R. (1998). Neuropsychological functioning in HIV-positive African-American women with a history of drug use. Journal of the National Medical Association, 90, 665-674.
57. Meade, C. S., Lowen, S. B., MacLean, R. R., Key,M. D., & Lukas, S. E. (2011). fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence. Psychiatry Research, 192, 167-175.
58. Millikin, C. P., Rourke, S. B., Halman, M. H., & Power, C. (2003). Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning. Journal of Clinical and Experimental Neuropsychology, 25, 201-215.
59. Morgan, E. E., Woods, S. P., Delano-Wood, L., Bondi, M. W., Grant, I., & HIV Neurobehavioral Research Program (HNRP) Group. (2011). Intraindividual variability in HIV infection: Evidence for greater neurocognitive dispersion in older HIV seropositive adults. Neuropsychology, 25, 645-654.
60. Morgan, E. E., Woods, S. P., Smith, C., Weber, E., Scott, J. C., Grant, I., & HIV Neurobehavioral Research Program (HNRP) Group. (2012). Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND). AIDS and Behavior, 16, 2279-2285.
61. Morgello, S., Estanislao, L., Ryan, E., Gerits, P., Simpson, D., Verma, S., Sharp, V. (2005). Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIVinfected individuals. AIDS, 19, S116-S122.
62. Perry, W., Carlson, M. D., Barakat, F., Hilsabeck, R. C., Schiehser, D. M., Matthews, C., & Hassanein, T. I. (2005). Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV. AIDS, 19, S79-S84.
63. Rentz, D. M., Locascio, J. J., Becker, J. A., Moran, E. K., Eng, E., Buckner, R. L., Johnson, K. A. (2010). Cognition, reserve, and amyloid deposition in normal aging. Annals of Neurology, 67, 353-364.
64. Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., Grant, I. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10, 1-14.
65. Ryan, E. L., Morgello, S., Isaacs, K., Naseer, M., & Gerits, P. (2004). Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology, 62, 957-962.
66. Sacktor, N., Skolasky, R., Selnes, O. A., Watters, M., Poff, P., Shiramizu, B., Valcour, V. (2007). Neuropsychological test profile differences between young and old human immunodeficiency viruspositive individuals. Journal of Neurovirology, 13, 203-209.
67. Satz, P. (1993). Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. Neuropsychology, 7, 273-295.
68. Satz, P., Morgenstern, H., Miller, E. N., Selnes, O. A., McArthur, J. C., Cohen, B. A., Visscher, B. (1993). Low education as a possible risk factor for cognitive abnormalities inHIV-1: Findings fromthemulticenter AIDS Cohort Study (MACS). Journal of Acquired Immune Deficiency Syndromes, 6, 503-511.
69. Selnes, O. A., Jacobson, L., Machado, A. M., Becker, J. T., Wesch, J., Miller, E. N., McArthur, J. C. (1991). Normative data for a brief neuropsychological screening battery. Multicenter AIDS Cohort Study. Perceptual Motor Skills, 73, 539-550.
70. Sherman, K. E., Rouster, S. D., Chung, R. T., & Rajicic, N. (2002).Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical Infectious Diseases, 34, 831-837.
71. Shimizu, S. M., Chow, D. C., Valcour, V., Masaki, K., Nakamoto, B., Kallianpur, K. J., & Shikuma, C. (2011). The impact of depressive symptoms on neuropsychological performance tests in HIV-infected individuals: A study of the Hawaii Aging with HIV Cohort. World Journal of AIDS, 1, 139-145.
72. Simpson, C. F., Boyd, C. M., Carlson, M. C., Griswold, M. E., Guralnik, J. M., & Fried, L. P. (2004). Agreement between self-report of disease diagnoses and medical record validation in disabled older women: Factors that modify agreement. Journal of the American Geriatrics Society, 52, 123-127.
73. Smith, A. (1982). Symbol DigitModalities Test (SDMT) manual (revised). Los Angeles, CA: Western Psychological Association.
74. Stein, J. H., Klein, M. A., Bellehumeur, J. L., McBride, P. E., Wiebe, D. A., Otvos, J. D., & Sosman, J. M. (2001). Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation, 104, 257-262.
75. Stern, R. A., Silva, S. G., Chaisson, N., & Evans, D. L. (1996). Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodefiency virus-1 infection. Archives of Neurology, 53, 148-153.
76. Stuss, D. T., Stethem, L. L., & Pelchat, G. (1988). Three tests of attention and rapid information processing: An extension. Clinical Neuropsychologist, 2, 246-250.
77. Tate, D. F., Delong, A., McCaffrey, D. E., Kertesz, K., Paul, R. H., Conley, J., Hogan, J. W. (2011). Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients. Archives of Clinical Neuropsychology, 26, 614-623.
78. Thames, A. D., Foley, J. M., Panos, S. E., Singer, E. J., & Hinkin, C. H. (2011a). Cognitive reserve masks the neurobehavioral expression of HIV neurological disorder in older adults. Neurobehavioral HIV Medicine, 3, 87-93.
79. Thames, A. D., Kim, M. S., Becker, B. W., Foley, J. M., Hines, L. J., Singer, E. J., Hinkin, C. H. (2011b). Medication and finance management among HIV-infected adults: The impact of age and cognition. Journal of Clinical and Experimental Neuropsychology, 33, 200-209.
80. Tipping, B., de Villiers, L., Wainwright, H., Candy, S., & Bryer, A. (2007). Stroke in patients with human immunodeficiency virus infection. Journal of Neurology, Neurosurgery, and Psychiatry, 78, 1320-1324.
81. Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007). Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. Journal of Clinical Endocrinology and Metabolism, 92, 2506-2512.
82. Tucker, J. S., Orlando, M., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2004). Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychology, 23, 363-370.
83. Valcour, V., Paul, R., Neuhaus, J., & Shikuma, C. (2011). The effects of age and HIV on neuropsychological performance. Journal of the International Neuropsychological Society, 17, 190-195.
84. Valcour, V., Yee, P., Williams, A. E., Shiramizu, B., Watters, M., Selnes, O., Sacktor, N. (2006). Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection: The Hawaii Aging with HIV Cohort. Journal of Neurovirology, 12, 387-391.
85. von Giesen, H. J., Baecker, R., Hefter, H., & Arendt, G. (2001). Depression does not influence basal gangliamediated psychomotor speed in HIV-1 infection. Journal of Neuropsychiatry & Clinical Neurosciences, 13, 88-94.
86. Wechsler, D. (1997).Wechsler adult intelligence scale (3rd ed.). San Antonio, TX: Psychological Corporation.
87. Weiss, J. J., Osorio, G., Ryan, E., Marcus, S. M., & Fishbein, D. A. (2010). Prevalence and patient awareness of medical comorbidities in an urban AIDS clinic. AIDS Patient Care and STDs, 24, 39-48.
88. Wetzel, L., & Boll, T. (1987). Short Category Test, booklet format. Los Angeles, CA: Western Psychological Services.
89. Wright, E. J., Grund, B., Robertson, K., Brew, B. J., Roediger, M., Bain, M. P., Price, R. W. (2010). Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology, 75, 864-873.